Spevigo Injection
Product Images NDC 0597-0035

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Spevigo (NDC 0597-0035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Spesolimab 01)

FDA Label Image

Principal Display Panel (450 mg/7.5 mL Vial Carton)

Principal Display Panel (450 mg/7.5 mL Vial Carton)
Packaging label for Spevigo (spesolimab-sbzo) injection, 450 mg/7.5 mL per vial (60 mg/mL) for intravenous infusion after dilution. The carton contains two single-dose vials, totaling a complete dose of 900 mg. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT. The label includes usage instructions to discard unused portions and a QR code for additional information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.